| Dr Rochelle Eun-a Lee-mcnulty, PSYD | |
|
142 Delmar St, San Francisco, CA 94117-4522 | |
| (818) 216-3040 | |
| Not Available |
| Full Name | Dr Rochelle Eun-a Lee-mcnulty |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 142 Delmar St, San Francisco, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144327834 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 20664 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rochelle Eun-a Lee-mcnulty, PSYD 1309 Evans Ave, San Francisco, CA 94124-1705 Ph: (415) 206-7618 | Dr Rochelle Eun-a Lee-mcnulty, PSYD 142 Delmar St, San Francisco, CA 94117-4522 Ph: (818) 216-3040 |
News Archive
Despite the existence of effective programs for treating alcohol dependencies and disorders, less than a quarter of people who are diagnosed actually seek treatment. In a recent study by Columbia University's Mailman School of Public Health researchers report that people diagnosed with alcoholism at some point in their lifetime were more than 60% less likely to seek treatment if they believed they would be stigmatized once their status is known.
Universal screening of all hospital admissions for infection with SARS-CoV-2 is highly inefficient as a screening method in regions with a low prevalence of COVID-19 in the absence of high-risk factors.
About eight years ago the WHO put out a call saying that we needed data that better represented real world patients. Our ambition was to create evidence earlier in the life cycle of medicine that better represented the population that would...
Celldex Therapeutics, Inc. today announced that the first patient has been treated in a randomized Phase 2b study of the Company's CDX-011 (glembatumumab vedotin) antibody drug conjugate in glycoprotein NMB (GPNMB) expressing advanced, refractory breast cancer patients. CDX-011 targets the protein GPNMB, which is over expressed in a variety of cancers including breast cancer, melanoma, and brain tumors.
Advion, Inc., a leading systems and consumables developer for the life sciences industry, announced today the availability of the inert Atmospheric Solids Analysis Probe, or iASAP, for easy sampling and fast analysis of air-sensitive compounds such as metal catalysts and organometallics.
› Verified 9 days ago
B L. Elliott, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 747 Front St, San Francisco, CA 94111 Phone: 707-508-6341 | |
Dr. David Tim Lewis, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 703 Market St Ste 1208, San Francisco, CA 94103 Phone: 415-350-9611 | |
Candy Ho Katoa, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 401 Parnassus Ave, Lp 488, San Francisco, CA 94143 Phone: 415-476-7133 | |
Stephanie Lauren Post, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1630 Lombard St, San Francisco, CA 94123 Phone: 703-901-6833 | |
Anett Atman, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3600 California St, San Francisco, CA 94118 Phone: 415-820-9612 | |
Dr. Andrea Samuels, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1947 Divisadero St Ste 1d, San Francisco, CA 94115 Phone: 510-847-4858 | |
Timothy Kim, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1610 Scott St, San Francisco, CA 94115 Phone: 510-365-5066 |